,,ii  #aacth ,,congress  #ast ,session  
,s4 #fba  ,,in ,,the ,,senate ,,of ,,the
 ,,united ,,states  ,march #bj1 #bjac   
,mr4 ,manchin 7for himself1 ,mr4 ,kirk1 
,mrs4 ,feinstein1 ,mr4 ,rockefeller1    
,mrs4 ,gillibrand1 and ,mr4 ,schumer7   
introduced the following bill2 which was
 read twice and referred to the         
,committee on the ,judiciary  ,a ,,bill 
,to amend the ,controlled ,substances   
,act to make any substance containing   
hydrocodone a schedule ,,ii drug4  #a4  
,short title ,this ,act may be cited as 
the ,safe ,prescribing ,act of #bjac4   
#b4 ,hydrocodone amendment  7a7 ,in     
general ,schedule ,,iii7d7 in section   
#bjb of the ,controlled ,substances ,act
 7#ba ,u4,s4,c4 #hab7 is amended by--   
7#a7 striking paragraphs 7#c7 and 7#d72 
and  7#b7 redesignating paragraphs 7#e71
 7#f71 7#g71 and 7#h7 as paragraphs     
7#c71 7#d71 7#e71 and 7#f71             
respectively4  7b7 ,effective date ,the 
amendments made by subsection 7a7 shall 
take effect on the date that is #f      

months after the date of enactment of   
this ,act4  #c4 ,physical security      
requirements ,notwithstanding the       
amendments made by section #b1 the      
,attorney ,general shall immediately1   
without regard to chapter #e of title   
#e1 ,united ,states ,code1 amend section
 #acja4gb of title #ba1 ,code of        
,federal ,regulations1 relating to the  
physical security controls for          
non-practitioners1 narcotic treatment   
programs and compounders for narcotic   
treatment programs1 and storage areas   
for controlled substances1 to allow1 for
 the #c-year period beginning on the    
date of enactment of this ,act1         
manufacturers and distributors to store 
hydrocodone combination products in     
accordance with the physical security   
requirements for schedule ,,iii1 ,,iv1  
and ,v controlled substances4  #d4 ,,gao
 report  7a7 ,in general ,not later than
 #ah months after the date of enactment 
of this ,act1 the ,comptroller ,general 
of the ,united ,states shall submit to  

,congress a report on the               
reclassification of hydrocodone products
 under this ,act4  7b7 ,contents ,the   
report required under subsection 7a7    
shall include--  7#a7 an assessment of  
the degree to which the reclassification
 of hydrocodone products under this ,act
 impacts the ability of patients with   
legitimate medical needs1 particularly  
those in rural areas and nursing home   
facilities1 to access adequate pain     
management2 and  7#b7 recommendations   
necessary to address issues1 if any1    
relating to patient access to adequate  
pain management4